| Literature DB >> 25028604 |
Bing Guo1, Kritaya Kongsuwan2, Paul L Greenwood3, Guanghong Zhou4, Wangang Zhang4, Brian P Dalrymple5.
Abstract
BACKGROUND: The expression of genes encoding proteins involved in triacyglyceride and fatty acid synthesis and storage in cattle muscle are correlated with intramuscular fat (IMF)%. Are the same genes also correlated with IMF% in sheep muscle, and can the same set of genes be used to estimate IMF% in both species?Entities:
Keywords: Cattle; Gene expression phenotype; IMF%; Sheep
Year: 2014 PMID: 25028604 PMCID: PMC4099020 DOI: 10.1186/2049-1891-5-35
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Rankings of genes in various datasets and average ranking
| cell death-inducing dffa-like effector a | 11 | 4 | 12 | |||
| acyl-CoA synthetase medium-chain family member 1 | 16 | 35 | 23 | |||
| adiponectin | 17 | 46 | 25 | 8 | ||
| fatty acid binding protein 4,adipocyte | 24 | 54 | 19 | |||
| perilipin1 | 25 | 15 | 49 | 6 | ||
| tumor suppressor candidate 5 | 54 | 73 | 63 | 13 | TAG | |
| lipoprotein lipase | 62 | 123 | 473 | 23 | EMMIX A8 | |
| mal, T-cell differentiation protein 2 | 67 | 33 | 177 | 16 | FA | |
| peroxisome proliferator-activated receptor gamma | 73 | 117 | 152 | 19 | ||
| diacylglycerol o-acyltransferase 2 | 74 | 6 | 30 | |||
| phosphate O-acyltransferase 2 | 100 | 21 | 118 | 14 | ||
| g0/g1switch 2 | 123 | 223 | 72 | 20 | EMMIX A | |
| fatty acid synthase | 167 | 39 | 17 | 9 | ||
| thyroid hormone responsive | 187 | 13 | 1 | |||
| ELOVL fatty acid elongase 6 | 231 | 34 | 6 | 7 | ||
| transketolase | 244 | 229 | 106 | 26 | PPARG | |
| cell death-inducing DFFA-like effector c | 272 | 41 | 61 | 15 | TAG | |
| cytochrome b5 type A (microsomal) | 307 | 64 | 483 | 27 | PPARG | |
| betaine-homocysteine S-methyltransferase 2 | 317 | 207 | 304 | 28 | FA | |
| retinol binding protein 4, plasma | 346 | 139 | 78 | 21 | ||
| acyl-CoA synthetase short-chain family member 2 | 440 | 19 | 43 | 12 | ||
| arylsulfatase family, member K | 447 | 948 | 502 | 42 | ||
| stearoyl-CoA desaturase | 472 | 9 | 22 | 10 | ||
| acetyl-CoA carboxylase alpha | 484 | 56 | 63 | 17 | ||
| atp citrate lyase | 535 | 148 | 16 | 18 | ||
| plastin1 | 659 | 502 | 6,513 | 49 | TAG9 | |
| transferrin | 742 | 310 | 20 | 22 | PPARG | |
| carnitine palmitoyltransferase 2 | 782 | 664 | 528 | 44 | EMMIX A | |
| phosphoenolpyruvate carboxykinase 1 | 859 | 20 | 13 | 11 | TAG | |
| protein tyrosine phosphatase-like, member b | 884 | 275 | 479 | 37 | ||
| adipogenin | 937 | 183 | 36 | 24 | TAG | |
| phosphoenolpyruvate carboxykinase 2 (mitochondrial) | 972 | 92 | 1,629 | 34 | FA | |
| integrator complex subunit 9 | 984 | 1,183 | 80 | 36 | PPARG | |
| phosphodiesterase 3B, cGMP-inhibited | 1,426 | 206 | 1,135 | 40 | FA | |
| alkaline ceramidase 3 | 1,519 | 683 | 969 | 52 | ||
| apolipoprotein A-I | 1,521 | 3,264 | 119 | 45 | EMMIX A | |
| periplasmic arylsulfatase | 1,865 | 114 | 7,806 | 43 | EMMIX A | |
| isocitrate dehydrogenase 1 (NADP+), soluble | 2,070 | 320 | 210 | 39 | ||
| apolipoprotein E | 2,224 | 227 | 424 | 41 | EMMIX A | |
| glutathione S-transferase alpha 1 | 2,302 | 998 | 3 | 29 | PPARG | |
| sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 | 2,341 | 3,667 | 172 | 53 | EMMIX A | |
| alanyl (membrane) aminopeptidase | 2,703 | 2,091 | 87 | 47 | FA | |
| hydroxysteroid (17-beta) dehydrogenase 12 | 2,726 | 74 | 457 | 35 | PPARG9 | |
| clusterin | 2,968 | 65 | 136 | 30 | ||
| 3-hydroxybutyrate dehydrogenase, type 1 | 3,240 | 8 | 1,797 | 31 | EMMIX A | |
| acyl-CoA synthetase short-chain family member 3 | 3,689 | 137 | 347 | 38 | PPARG | |
| malic enzyme 1, NADP(+)-dependent, cytosolic | 3,741 | 69 | 2,457 | 46 | EMMIX A | |
| S100 calcium binding protein G | 4,009 | 61 | 26 | 25 | TAG | |
| insulin induced gene 1 | 4,562 | 412 | 31 | 33 | FA | |
| glucose-6-phosphate dehydrogenase | 4,918 | 982 | 95 | 51 | PPARG | |
| glycerol-3-phosphate acyltransferase, (mitochondrial) | 5,886 | 1,364 | 185 | 55 | TAG9 | |
| fructose-1, 6-bisphosphatase 1 | 6,604 | 706 | 2 | 32 | FA | |
| quinolinate phosphoribosyltransferase | 7,565 | 329 | 137 | 50 | PPARG | |
| aminolevulinate dehydratase | 9,051 | 422 | 347 | 54 | PPARG | |
| CCAAT/enhancer binding protein (C/EBP), alpha | 10,545 | 593 | 65 | 48 | PPARG | |
1Full list of genes and probes is included as Additional file 1: Table S1.
2Genes in bold were included in the 30 gene set correlated with IMF% in cattle and sheep generated by the current study.
3Gene rank of the correlation coefficients in Sheep correlation dataset.
4Gene rank of the correlation coefficients in Cattle correlation dataset.
5Gene rank of DE value in Cattle DE dataset.
6Genes in this table were ranked from 1–55 based on their ranking in each of the cattle and the sheep correlation datasets. The average ranking across the two datasets was calculated and the genes were again ranked from 1 to 55.
7These genes were both included in TAG, FA and PPARG gene sets and annotated with the GO term “lipid metabolic process” and in EMMIX cluster A.
8Genes were annotated with the GO term “lipid metabolic process” and in EMMIX cluster A.
9Genes were included in each corresponding gene set in the current analysis based on the biological functions. But these genes were not the part of TAG, FA and PPARG gene sets in our previous work [4].
Gene enrichment analysis of EMMIX Cluster A
| ≥0.9 | 571 | 121 | 136 | 7.66E-13 | 8.13E-09 | 30 | 4.57 |
| ≥0.8 | 768 | 153 | 170 | 8.56E-12 | 9.09E-08 | 31 | 4.12 |
| ≥0.7 | 920 | 177 | 198 | 8.38E-10 | 2.97E-06 | 32 | 3.37 |
| ≥0.6 | 1109 | 210 | 237 | 1.79E-08 | 3.80E-05 | 33 | 2.93 |
| ≥0.5 | 1342 | 248 | 282 | 8.12E-08 | 1.08E-04 | 35 | 2.67 |
1Probability of genes to be located in cluster A.
2Genes with positive coordinates in all three datasets, see Additional file 1: Table S1 sheet “Genes with positive coordinates”.
3Genes with all negative coordinates in all the three datasets.
4Number of genes enriched in “lipid metabolic process” GO term from genes with all positive coordinates in all the three datasets.
5Enrichment (N, B, n, b) is defined as follows: N - is the total number of genes; B - is the total number of genes associated with a specific GO term; n - is the number of genes in the top of the user's input list or in the target set when appropriate; b - is the number of genes in the intersection; Enrichment = (b/n) / (B/N).
Figure 1Three dimensional plot of cattle and sheep correlation datasets and cattle DE dataset. Data points for 13,330 probe sets with reliable data in all three datasets. The 212 genes with expression positively correlated with IMF% generated from cattle correlation and DE datasets in our previous study [4]. A) and B) are two different visual angles of this three dimensional plot.
Correlation between gene expression and IMF%
| 20 sheep | 0.52 | 0.51 |
| 48 cattle | 0.40 | 0.46 |
| 36 cattle1 | 0.61 | 0.60 |
| NSW control group | −0.40 | −0.04 |
148 cattle excluding the NSW control group.
Figure 2Relationship between IMF% and gene expression in Brahman cattle. A) IMF% and CIDEA expression in WA control and HGP treated animals separately. B) IMF% and CIDEA expression in WA cattle. C) IMF% and IMF 5 gene set expression in WA control and HGP treated animals separately. D) IMF% and IMF 5 gene set expression in WA cattle.
Figure 3Relationship between IMF% and gene expression in 20 sheep. A) IMF% and CIDEA expression. B) IMF% and IMF 5 gene set expression.
Comparison of the performance of different measures and estimators of IMF%
| NIRS measured IMF% | 141 | 2.37 ± 1.004 | 1.90 ± 0.83 | 0.001 | 198 |
| Ultrasound estimated IMF% | 173 | 2.66 ± 0.724 | 2.93 ± 0.54 | 1.000 | N/A5 |
| NIRS measured IMF% | 22 | 2.07 ± 0.774 | 1.79 ± 0.54 | 0.340 | 294 |
| IMF% calculated by | 22 | 2.30 ± 1.196 | 1.60 ± 1.14 | 0.080 | 148 |
| IMF% calculated by IMF 5 gene set formula | 22 | 2.66 ± 1.046 | 1.30 ± 0.92 | 0.003 | 26 |
| Ranking animals using | 22 | 9.50 ± 6.627 | 13.20 ± 6.16 | 0.100 | 156 |
| Ranking animals using IMF 5 gene set | 22 | 7.20 ± 5.478 | 15.10 ± 4.99 | 0.0026 | 22 |
| Ranking animals using TAG gene set | 22 | 7.00 ± 4.528 | 15.30 ± 5.48 | 0.0017 | 20 |
| 22 | 13.09 ± 0.447 | 12.83 ± 0.38 | 0.080 | 130 | |
| IMF 5 gene set DE | 22 | 0.25 ± 0.389 | −0.27 ± 0.31 | 0.0014 | 24 |
| TAG gene set DE | 22 | 0.28 ± 0.369 | −0.27 ± 0.33 | 0.00076 | 20 |
1Number of animals used for the analysis.
2For the test that average measured or estimated IMF%/gene expression/ranking in HGP-treated animals is lower than in control animals.
3The sample size predicted to be required to observe a significant result (P < 0.05) with 95% confidence intervals.
4Mean values, standard deviation and P-values are calculated using original record data.
5Ultrasound estimated IMF% did not detect an effect of the expected direction.
6Mean values, standard deviation and P-values are calculated using rescaled gene expression values.
7Mean values, standard deviation and P-values of ranking and DE of CIDEA are calculated using rescaled gene expression values.
8Mean values, standard deviation and P-values of ranking calculation of IMF 5 gene set and TAG gene set are based on Mann-Witney test.
9Mean values, standard deviation and P-values of IMF 5 gene set and TAG gene set DE are calculated using rescaled gene expression values.
Figure 4Correlation between ultrasound estimated IMF% and NIRS measured IMF% in Brahman cattle.
Figure 5Diagrammatic relationship of measured IMF% and gene expression of IMF 5 gene set over time. A) Linear parallel portions of the curves for IMF% and gene expression have been separated for display purposes only. B) Profile of the concentration of circulating HGP after implantation. C), D) and E) Relationship between IMF% and gene expression of IMF 5 gene set at different time points after HGP implantation. The red solid lines represented control subgroup; blue ones represented the HGP treated subgroup.